Leaflet APLEONA 20mg/ml + 5mg/ml 20mg / 5mg / ml ophthalmic drops solution

Product code:
W72207001
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
dorzolamide (glaucoma agent)
ATC
S01ED51 — Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Dorzolamide is a medication used for the treatment of glaucoma and ocular hypertension. It is a carbonic anhydrase inhibitor that reduces the production of aqueous humor, thereby lowering intraocular pressure.

The medication is available as eye drops and is usually administered two or three times daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with Dorzolamide. Follow the administration instructions to ensure treatment effectiveness.

General data about APLEONA 20mg/ml + 5mg/ml 20mg / 5mg / ml

Substance:
dorzolamide
Product code:
W72207001
Concentration:
20mg / 5mg / ml
Pharmaceutical form:
ophthalmic drops solution
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
GENETIC S.P.A. - ITALIA
Holder:
PHARMASELECT INTERNATIONAL BETEILIGUNGS GMBH - AUSTRIA
Number:
16867/2026/01
Shelf life:
2 years-after packing for marketing;after the first opening of the bottle-28 de days

Pharmaceutical forms available for dorzolamide

Concentrations available for dorzolamide

  • 20mg/5mg/ml
  • 20mg/ml

Combinations with other substances